Thrombin Market to Exhibit CAGR of 4.1% Despite Limited Product Innovations | Fortune Business Insights

The Global Thrombin Market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025. . Thrombin inhibitors play a major part in delaying blood clotting.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Thrombin Market is favored by the rising incidence of thrombosis among people, globally. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.” In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market and it is estimated to expand at a CAGR of 4.1%. As of 2018, the global thrombin market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.

Thrombosis can be caused due to mere sedentary lifestyle habits such as smoking and some other factors such as heart failures, aging, and cancer. Thrombin inhibitors play a major part in delaying blood clotting. The healing properties of thrombin, along with its ability to minimize bleeding during surgical procedures has led to an increase in demand for thrombin over the years.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/thrombin-market-100170

Widespread Applications of Thrombin to Boost Global Market

Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.

Bovine-derived thrombin was successfully used in patients with hemodialysis. Bovine thrombin is massively helpful in treating hemorrhages in hemodialysis, wherein an excessive amount of blood is lost. The extent of blood losses in hemodialysis can lead to various disorders and may also prove fatal in some cases. Thus, bovine-derived thrombin is given huge emphasis and healthcare professionals have prioritized thrombin for treating hemorrhages. The thrombin market is therefore forecast to witness a high demand for bovine-derived thrombin in the com9ing years.

Recothrom to Emerge as The Most Widely Used Product Type

As surgical blood loss has been prioritized by surgeons and healthcare professionals worldwide, there is an increasing need for an efficient solution to minimize such severe losses. Recothrom was initially manufactured by a US-based company, ZymoGenetics. After involvement from Bayer Healthcare, Recothrom was later acquired by Baxter International. The 2018 acquisition of Recothrom by Baxter has proved fruitful to the overall market. As of now, Recothrom is the only drug that has been clinically approved for commercial use as a recombinant thrombin brand. Furthermore, Recothrom finds applications in cases where standard surgical procedures such as suture or cautery are ineffective.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170

Besides Baxter, there have been significant activities from other companies that have contributed to the growth of the global thrombin market. Attractive business strategies of companies such as Pfizer have had a positive impact on the overall market. Pfizer’s has emerged as the leading company, backed by high clinical efficiency of its product ‘Thrombin JMI’. Some other companies that are operating in the global thrombin market are Johnson & Johnson Services Inc., Shanghai RAAS Blood Products Co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/thrombin-market-to-exhibit-cagr-of-41-despite-limited-product-innovations-fortune-business-insights/513505

Source: MarketersMedia

Release ID: 513505

Latest News

Kenya patient free of Ebola, as Congo, Uganda fight outbreak

Jul 16, 2019

NAIROBI, Kenya — Kenya remains free from Ebola as test results show that a sick woman does not have the deadly hemorrhagic fever, while neighboring Uganda and Congo battle a stubborn outbreak of the disease. Kenya's Health Minister Sicily Kariuki Monday announced that a patient isolated at the Kericho County Referral Hospital does not have Ebola. "The results of tests carried out by the Kenya Medical Research Institute laboratories on the 36-year-old lady currently admitted in the isolation unit of the Kericho County Referral hospital have been confirmed to be negative for the Ebola virus disease and other hemorrhagic fevers,"...

Egypt demands Christie's halt auction of King Tut statue

Jul 16, 2019

CAIRO — Egypt has tried to halt the auction of a 3,000-year-old stone sculpture of the famed boy pharaoh Tutankhamun at Christie's in London, while the auction house said its sale was legal. The statue — a brown quartzite head depicting King Tut — is scheduled to be auctioned off in July, and could generate more than $5 million, according to Christie's. The artifact features King Tut's full mouth with slightly drooping lower lips and almond-shaped eyes. For many, King Tut is the ultimate symbol of ancient Egypt's glory. Howard Carter discovered the pharaoh's nearly intact tomb in 1922 in...

Egypt says ancient cemetery found at Giza famed pyramids

Jul 16, 2019

CAIRO — Egypt's Antiquities Ministry says archaeologists have uncovered part of an ancient cemetery near the country's famed pyramids on the Giza plateau just outside Cairo. Mostafa Waziri, secretary general of the Supreme Council of Antiquities, says Saturday the cemetery houses burial shafts and tombs of top officials and a fine limestone statue from the Old Kingdom's Fifth Dynasty (2465-2323 B.C.). Ashraf Mohi, the head of the Giza Plateau archaeological site, says scientists know that the cemetery had been reused extensively in the Late Period (664-332 B.C.), as archeologists found painted and decorated wooden anthropoid coffins, and wooden and clay...

AP Explains: Why this Ebola outbreak is a special challenge

Jul 16, 2019

JOHANNESBURG — More than 1,000 deaths have now been confirmed in eastern Congo's Ebola outbreak, the second-worst in history behind the West African one in 2014-16 that killed more than 11,300 people. Attacks on health workers are badly complicating efforts to contain one of the world's most notorious diseases. At least 85 have been wounded or killed since January. Here's a look at why the outbreak is especially challenging, even as a promising experimental vaccine is being used widely for the first time. Nervous health experts watch as the virus spreads in a dense, highly mobile population near the border...

New cyclone begins to make landfall in northern Mozambique

Jul 16, 2019

JOHANNESBURG — A powerful tropical cyclone began to make landfall on Thursday in Mozambique, just six weeks after Cyclone Idai devastated the central part of the country and left hundreds dead. Authorities carried out compulsory evacuations in cases where residents resisted warnings to flee. Cyclone Kenneth is expected to bring heavy rains and flooding to northeastern Mozambique, which was not hit by the earlier storm, and southern Tanzania, which told coastal residents to evacuate. The cyclone arrived in Mozambique north of the city of Pemba with maximum sustained winds of 220 kilometers (136 miles) per hour, the Joint Typhoon Warning...

About Us

Delivering news from all over the globe, StarJournal keeps you abreast with the greatest minds in science, be it researchers, theorists or even popularizers.

Contact us: sales[at]starjournals.com

Subscribe Now!